Verrica Pharmaceuticals Inc.
VRCA
$0.4891
$0.02264.85%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -76.58M | -84.99M | -86.93M | -80.74M | -67.00M |
| Total Depreciation and Amortization | 1.27M | 1.23M | 1.10M | 974.00K | 836.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.36M | 13.40M | 20.53M | 19.18M | 17.72M |
| Change in Net Operating Assets | 2.03M | 10.99M | -316.00K | 6.65M | 9.86M |
| Cash from Operations | -60.93M | -59.37M | -65.62M | -53.93M | -38.58M |
| Capital Expenditure | -27.00K | -254.00K | -303.00K | -351.00K | -362.00K |
| Sale of Property, Plant, and Equipment | 8.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -19.00K | -254.00K | -303.00K | -351.00K | -362.00K |
| Total Debt Issued | -- | 0.00 | 44.11M | 44.11M | 44.11M |
| Total Debt Repaid | -924.00K | -573.00K | -356.00K | -179.00K | -23.00K |
| Issuance of Common Stock | 39.79M | 154.00K | 154.00K | 4.00K | 30.31M |
| Repurchase of Common Stock | -- | -1.00K | -1.00K | -1.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.14M | -1.31M | -1.19M | -657.00K | -176.00K |
| Cash from Financing | 37.73M | -1.73M | 42.72M | 43.27M | 74.21M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.22M | -61.35M | -23.21M | -11.01M | 35.27M |